Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory


Identification and diagnosis of Cushing’s syndrome (CS) have historically been difficult due to the lack of commercially available, CE-IVD-marked testing options. Traditionally, laboratories developed in-house LC-MS-MS methods for dexamethasone measurement to detect CS. However, these in-house methods lacked inter-laboratory harmonization and resulted in a high false-positive rate. 

Join Federico Ponzetto, PhD, from the Department of Medical Sciences at the University of Turin to learn more about:

  • The clinical applications of dexamethasone testing
  • Diagnosis and epidemiology of CS
  • The current and new workflow of the dexamethasone suppression test
  • How Tecan’s Steroid Panel LC-MS-MS kit helps to reduce the false-positive rate and systematizes inter-laboratory results 
  • The automation potential of diagnostic workflows using equipment such as Freedom Evo® and Resolvex® A200